Mandate

Vinge advises Anyfin in a capital procurement of SEK 450 million

October 05, 2021 M&A

The new financing will be used for future internationalization, among other things, in conjunction with the company’s launch in Germany, and for future investments in technology and in order to broaden the product offering.

Anyfin helps its customers to reduce their interest costs by refinancing original loans and providing better offers in respect of the customers’ loans.

Vinge’s team primarily consisted of Johan LarssonCarl SanderEllinor WargenbrantStina Bengtsson and Eléonore Friberg.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026